Lifecome Biochemistry Co.,Ltd.

SZSE:002868 Stock Report

Market Cap: CN¥2.7b

Lifecome BiochemistryLtd Past Earnings Performance

Past criteria checks 0/6

Lifecome BiochemistryLtd's earnings have been declining at an average annual rate of -71.4%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 14.1% per year.

Key information

-71.4%

Earnings growth rate

-71.3%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate14.1%
Return on equity-113.4%
Net Margin-50.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Prospects Need A Boost To Lift Shares

Oct 04
Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Prospects Need A Boost To Lift Shares

Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 26% Plummet

Apr 21
Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 26% Plummet

Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Mar 06
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Revenue & Expenses Breakdown

How Lifecome BiochemistryLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002868 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24581-2936838
30 Jun 24603-2626934
31 Mar 24567-2436330
31 Dec 23507-2225528
30 Sep 23493-1404423
30 Jun 23416-1324123
31 Mar 23367-1234422
01 Jan 23330-1224022
30 Sep 22345-883923
30 Jun 22334-693925
31 Mar 22335-373624
31 Dec 21363-263825
30 Sep 21319-62823
30 Jun 21304142722
31 Mar 21317322822
31 Dec 20308432920
30 Sep 20324653821
30 Jun 20338673821
31 Mar 20318593718
31 Dec 19304573519
30 Sep 19311503419
30 Jun 19320593417
31 Mar 19323673515
31 Dec 18344753515
30 Sep 18341743214
30 Jun 18357802720
31 Mar 18368783018
31 Dec 17375863414
30 Sep 17383843811
30 Jun 1736479460
31 Mar 1738388470
31 Dec 1640192480
31 Dec 1538678460
31 Dec 1429631380
31 Dec 1329733410

Quality Earnings: 002868 is currently unprofitable.

Growing Profit Margin: 002868 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002868 is unprofitable, and losses have increased over the past 5 years at a rate of 71.4% per year.

Accelerating Growth: Unable to compare 002868's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 002868 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.08%).


Return on Equity

High ROE: 002868 has a negative Return on Equity (-113.41%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies